Physician

Adam Schatz, MD

According to 2025 Medicare claims, Adam Schatz, MD (NPI: 1316331705) practices urology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is IDAHO UROLOGIC INSTITUTE PA (NPI: 1689620692; TIN: 20-1300128) and primary practice location at 83642-6245. Schatz is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Schatz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 560 traditional Medicare patients, billed 7,856 HCPCS/CPT codes, and received $163,848 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,859 prescription claims across 540 beneficiaries totaling $230,207 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 73 claims. Open Payments data shows 57 records totaling $98,970. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,879 to $230,207. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	47	179	$8,861
2021	364	9,708	$122,765
2022	486	6,583	$127,569
2023	571	8,610	$171,395
2024	560	7,856	$163,848

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	59	104	$2,879
2017	21	31	$326
2018	27	48	$1,466
2019	27	51	$22,921
2020	18	25	$364
2021	201	515	$20,282
2022	429	1,180	$118,007
2023	504	1,586	$217,071
2024	540	1,859	$230,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	25	$21,493
2023	N/R	94	$34,159
2024	N/R	73	$39,890

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	183	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	273	364	$57
84153	Psa (prostate specific antigen) measurement, total	157	190	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	276	364	$11
36415	Insertion of needle into vein for collection of blood sample	152	173	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	175	7,686	$114,522
Gemtesa	Vibegron	111	4,365	$68,604
Testosterone	Testosterone	41	1,450	$11,606
Tamsulosin Hcl	Tamsulosin Hcl	575	40,540	$6,481
Tolterodine Tartrate Er	Tolterodine Tartrate	34	2,400	$5,290

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	28	$31,129
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	34	$8,640
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	11	$121

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$523	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	32	$98,447	Ortho-Clinical Diagnostics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$107,777	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for Adam Schatz, MD?

Tedicare shows public-source Medicare data for Adam Schatz, MD (NPI 1316331705), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Schatz, MD have ACO affiliation data?

Adam Schatz, MD is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Adam Schatz, MD?

Adam Schatz, MD is linked to IDAHO UROLOGIC INSTITUTE PA (billing NPI 1689620692) in the available physician profile data.

Does Adam Schatz, MD have Open Payments data?

Adam Schatz, MD has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.